ConvaTec Group will pay up to $450m to buy Triad Life Sciences and enter the fast-growing wound biologics market.
Terms of the deal, announced on 28 January, call for ConvaTec to pay $125m upfront for Triad. ConvaTec has also agreed to pay two additional $25m payments for “short-term”...